FY2025 · ended Dec 31, 2025 · Revenue $27.48M, -34.3% YoY · Filed Mar 4, 2026
Sensus Healthcare, Inc. (SRTS) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $27.5 million and a net loss of $7.7 million. Free cash flow was $332,000. As of Jun 30, 2026 it held $15.2 million in cash and investments and $343,000 in total debt.
Revenue (TTM)
$17.51M
-53.4% vs year-ago TTM
Net income (TTM)
$-15.48M
-1726.1% vs year-ago TTM
Operating cash flow (TTM)
$-6.80M
-290.6% vs year-ago TTM
Free cash flow (TTM)
$-6.97M
-299.6% vs year-ago TTM
EPS (TTM)
$-0.94
-1722.8% vs year-ago TTM
Dividend per share
None
Shares outstanding
16.46M
-0.2% vs prior year
Net cash
$14.84M
as of Jun 30, 2026
Operating margin
-75.7%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- SRTS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boca Raton, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1494891
- Former names
- Sensus Healthcare, LLC (until Dec 30, 2015)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $27.5M | $41.8M | $24.4M | $44.5M | $27.0M |
| Operating income | -$10.3M | $8.1M | -$382,000 | $14.8M | $4.1M |
| Net income | -$7.7M | $6.6M | $485,000 | $24.2M | $4.1M |
| Diluted EPS | -$0.47 | $0.41 | $0.03 | $1.46 | $0.25 |
| Operating cash flow | $528,000 | -$831,000 | -$2.1M | -$1.4M | -$286,000 |
| Free cash flow | $332,000 | -$1.1M | -$2.4M | -$1.6M | -$414,000 |
| Total assets | $53.0M | $62.2M | $53.7M | $56.7M | $32.2M |
| Total liabilities | $4.9M | $6.3M | $4.9M | $8.7M | $6.2M |
| Stockholders' equity | $48.1M | $55.8M | $48.8M | $48.1M | $26.0M |
| Cash and investments | $22.1M | $22.1M | $23.1M | $25.5M | $14.5M |
| Total debt | $471,000 | $602,000 | $783,000 | $1.0M | $174,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Material agreement
|
Jun 5, 2026 | Jun 2, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2026 | May 29, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
All 407 Sensus Healthcare, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.